EHMT2 and neoplasm: To comprehensively explore the role of EHMT2 in EGFR-TKI resistance, we next investigated the effects of the above treatments on cell migration and tumor sphere formation, phenomena that are considered characteristics of the malignant phenotype in EGFR-TKI-resistant cells13,14.